PL353994A1 - Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives - Google Patents

Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Info

Publication number
PL353994A1
PL353994A1 PL00353994A PL35399400A PL353994A1 PL 353994 A1 PL353994 A1 PL 353994A1 PL 00353994 A PL00353994 A PL 00353994A PL 35399400 A PL35399400 A PL 35399400A PL 353994 A1 PL353994 A1 PL 353994A1
Authority
PL
Poland
Prior art keywords
mesoprogestins
component
receptor modulators
progesterone receptor
female contraceptives
Prior art date
Application number
PL00353994A
Other languages
English (en)
Polish (pl)
Inventor
KristofChwalisz Kristof Chwalisz
WalterElger Walter Elger
GerdSchubert Gerd Schubert
Original Assignee
Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg filed Critical Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg
Publication of PL353994A1 publication Critical patent/PL353994A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
PL00353994A 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives PL353994A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38613399A 1999-08-31 1999-08-31
PCT/IB2000/002053 WO2001026603A2 (en) 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Publications (1)

Publication Number Publication Date
PL353994A1 true PL353994A1 (en) 2003-12-15

Family

ID=23524305

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353994A PL353994A1 (en) 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Country Status (28)

Country Link
EP (1) EP1605949A2 (xx)
JP (1) JP2003511399A (xx)
KR (1) KR20020038745A (xx)
CN (1) CN1384748A (xx)
AR (1) AR025455A1 (xx)
AU (1) AU781835B2 (xx)
BG (1) BG106441A (xx)
BR (1) BR0013711A (xx)
CA (1) CA2383650A1 (xx)
CO (1) CO5190694A1 (xx)
CZ (1) CZ2002707A3 (xx)
EA (1) EA006805B1 (xx)
EE (1) EE200200103A (xx)
HR (1) HRP20020265A2 (xx)
HU (1) HUP0202515A3 (xx)
IL (1) IL148415A0 (xx)
LT (1) LT5001B (xx)
LV (1) LV12940B (xx)
MX (1) MXPA02002186A (xx)
NO (1) NO20020998L (xx)
NZ (1) NZ517470A (xx)
PE (1) PE20010579A1 (xx)
PL (1) PL353994A1 (xx)
SI (1) SI20853A (xx)
SK (1) SK2982002A3 (xx)
UA (1) UA77150C2 (xx)
WO (1) WO2001026603A2 (xx)
YU (1) YU13902A (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
DE50304970D1 (de) * 2002-08-02 2006-10-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
EP1624848A4 (en) * 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE
US20050215535A1 (en) * 2004-03-24 2005-09-29 Kristof Chwalisz Sequential SPRM/progestin treatment
TW200603813A (en) * 2004-07-07 2006-02-01 Wyeth Corp Cyclic progestin regimens and kits
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
US9616073B2 (en) * 2009-04-14 2017-04-11 Laboratoire Hra-Pharma Method for on-demand contraception
CN110548034A (zh) * 2019-07-12 2019-12-10 广州莎蔓生物科技有限公司 一种怀孕阻断药物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
NZ226316A (en) * 1987-09-24 1991-10-25 Jencap Research Ltd Pharmaceutical contraceptive preparations and packages containing from 20-35 unit dosages comprising an estrogen and a progestin; the unit dosages having alternating estrogen and progestin dominance
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4429398C2 (de) 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP0787002B1 (de) * 1994-10-24 2006-12-13 Schering Aktiengesellschaft Kompetitive progesteronantagonisten zur bedarfsorientierten weiblichen fertilitätskontrolle
US6040340A (en) * 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
PL330916A1 (en) * 1996-06-25 1999-06-07 Akzo Nobel Nv Progestagen-antiprogestagen dosing schemes
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
CN1353717A (zh) * 1999-05-04 2002-06-12 莱加制药公司 四环黄体酮受体调节剂化合物及其方法

Also Published As

Publication number Publication date
BG106441A (bg) 2002-09-30
EP1605949A2 (en) 2005-12-21
HUP0202515A3 (en) 2004-06-28
AR025455A1 (es) 2002-11-27
CZ2002707A3 (cs) 2002-11-13
LV12940B (en) 2003-06-20
WO2001026603A3 (en) 2002-01-17
WO2001026603A2 (en) 2001-04-19
KR20020038745A (ko) 2002-05-23
MXPA02002186A (es) 2002-09-02
SK2982002A3 (en) 2002-07-02
SI20853A (sl) 2002-10-31
LT2002035A (lt) 2002-10-25
AU3215001A (en) 2001-04-23
PE20010579A1 (es) 2001-06-04
CA2383650A1 (en) 2001-04-19
YU13902A (sh) 2006-01-16
IL148415A0 (en) 2002-09-12
AU781835B2 (en) 2005-06-16
NO20020998D0 (no) 2002-02-28
EE200200103A (et) 2003-04-15
HRP20020265A2 (en) 2004-02-29
NO20020998L (no) 2002-03-14
LT5001B (lt) 2003-03-25
JP2003511399A (ja) 2003-03-25
BR0013711A (pt) 2002-05-07
HUP0202515A2 (hu) 2002-12-28
UA77150C2 (en) 2006-11-15
CN1384748A (zh) 2002-12-11
EA006805B1 (ru) 2006-04-28
CO5190694A1 (es) 2002-08-29
EA200200284A1 (ru) 2002-10-31
NZ517470A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
EG25606A (en) Glucocorticoid receptor modulators
HK1043788A1 (zh) 四環黃體酮受體調節劑化合物及方法
HUP0203680A3 (en) Controlled release hydrocodone formulations
IL147485A0 (en) Pharmaceutical compositions containing a selective estrogen receptor modulator
AU4686100A (en) Primary connector for pre-cast structures
IL143407A0 (en) Controlled release formulation of divalproex sodium
AU3950600A (en) Intrauterine contraceptive device
MXPA01011294A (es) Compuestos moduladores de receptor de progesterona tetraciclicos y metodos.
AU5025300A (en) Compositions for controlled release of the hormone gnrh and its analogs
IL154984A0 (en) Estrogen receptor modulators
HUP0202515A3 (en) Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
AU9621598A (en) Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive
IL146280A0 (en) Cyclocarbamate derivatives as progesterone receptor modulators
GB9927215D0 (en) Hormone receptor expression
IL148417A0 (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
HK1043789A1 (zh) 作為黃體酮受體調節劑的環硫代胺基甲酸鹽衍生物
HK1043989A1 (zh) 作為黃體酮受體調節劑的環胺基甲酸鹽衍生物
GB9913649D0 (en) Estrogen receptor
AU1901401A (en) Condom set for preventing premature ejaculation
IL142881A0 (en) Enzymatic resolution of selective estrogen receptor modulators
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
GB9916989D0 (en) Control of male fertility
AU7022600A (en) Initiation of oestrus
TW365160U (en) Device for preventing male^s incontinence problems

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)